Literature DB >> 15271800

Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase.

Yoshimitsu Taguchi1, Tadakazu Kondo, Mitsumasa Watanabe, Michihiko Miyaji, Hisanori Umehara, Yasunori Kozutsumi, Toshiro Okazaki.   

Abstract

Interleukin 2 (IL-2) rescued human natural killer (NK) KHYG-1 cells from apoptosis along with a reduction of ceramide. Conversely, an increase of ceramide inhibited IL-2-rescued survival. IL-2 deprivation-induced activation of acid sphingomyelinase (SMase) and inhibition of glucosylceramide synthase (GCS) and sphingomyelin synthase (SMS) were normalized by IL-2 supplementation. A phosphatidyl inositol-3 (PI-3) kinase inhibitor, LY294002, inhibited IL-2-rescued survival, but a mitogen-activated protein kinase inhibitor, PD98059, and an inhibitor of Janus tyrosine kinase/signal transducer and activator of transcription pathway, AG490, did not. LY294002 inhibited IL-2-induced reduction of ceramide through activation of acid SMase and inhibition of GCS and SMS, suggesting the positive involvement of PI-3 kinase in ceramide reduction through enzymatic regulation. Indeed, a constitutively active PI-3 kinase enhanced growth rate and ceramide reduction through inhibition of acid SMase and activation of GCS and SMS. Further, LY294002 inhibited IL-2-induced changes of transcriptional level as well as mRNA and protein levels in acid SMase and GCS but did not affect the stability of the mRNAs. These results suggest that PI-3 kinase-dependent reduction of ceramide through regulation of acid SMase, GCS, and SMS plays a role in IL-2-rescued survival of NK cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271800     DOI: 10.1182/blood-2004-03-0900

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Sphingomyelin synthase 1-generated sphingomyelin plays an important role in transferrin trafficking and cell proliferation.

Authors:  Abo Bakr Abdel Shakor; Makoto Taniguchi; Kazuyuki Kitatani; Mayumi Hashimoto; Satoshi Asano; Akira Hayashi; Kenichi Nomura; Jacek Bielawski; Alicja Bielawska; Ken Watanabe; Toshihide Kobayashi; Yasuyuki Igarashi; Hisanori Umehara; Hiroyuki Takeya; Toshiro Okazaki
Journal:  J Biol Chem       Date:  2011-08-19       Impact factor: 5.157

2.  Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.

Authors:  Amudhan Maniar; Xiaoyu Zhang; Wei Lin; Brian R Gastman; C David Pauza; Scott E Strome; Andrei I Chapoval
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

3.  Regulation of ceramide generation during macrophage apoptosis by ASMase and de novo synthesis.

Authors:  Shih Wei Wang; Payman Hojabrpour; Peng Zhang; Richard N Kolesnick; Urs P Steinbrecher; Antonio Gómez-Muñoz; Vincent Duronio
Journal:  Biochim Biophys Acta       Date:  2015-08-04

4.  Differential regulation of sphingomyelin synthesis and catabolism in oligodendrocytes and neurons.

Authors:  John P Kilkus; Rajendra Goswami; Sylvia A Dawson; Fernando D Testai; Eugeny V Berdyshev; Xianlin Han; Glyn Dawson
Journal:  J Neurochem       Date:  2008-06-28       Impact factor: 5.372

5.  Oxidized phosphatidylcholine formation and action in oligodendrocytes.

Authors:  Jingdong Qin; Fernando D Testai; Sylvia Dawson; John Kilkus; Glyn Dawson
Journal:  J Neurochem       Date:  2009-06-22       Impact factor: 5.372

6.  Lysosomal ceramide generated by acid sphingomyelinase triggers cytosolic cathepsin B-mediated degradation of X-linked inhibitor of apoptosis protein in natural killer/T lymphoma cell apoptosis.

Authors:  M Taniguchi; H Ogiso; T Takeuchi; K Kitatani; H Umehara; T Okazaki
Journal:  Cell Death Dis       Date:  2015-04-09       Impact factor: 8.469

7.  Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.

Authors:  Minsung Kim; Suhkneung Pyo; Chung Hyo Kang; Chong Ock Lee; Heung Kyoung Lee; Sang Un Choi; Chi Hoon Park
Journal:  PLoS One       Date:  2018-06-06       Impact factor: 3.240

Review 8.  Acid Sphingomyelinase Deficiency: A Clinical and Immunological Perspective.

Authors:  Carolina Pinto; Diana Sousa; Vladimir Ghilas; Andrea Dardis; Maurizio Scarpa; Maria Fatima Macedo
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

9.  Self-enhancement of hepatitis C virus replication by promotion of specific sphingolipid biosynthesis.

Authors:  Yuichi Hirata; Kazutaka Ikeda; Masayuki Sudoh; Yuko Tokunaga; Akemi Suzuki; Leiyun Weng; Masatoshi Ohta; Yoshimi Tobita; Ken Okano; Kazuhisa Ozeki; Kenichi Kawasaki; Takuo Tsukuda; Asao Katsume; Yuko Aoki; Takuya Umehara; Satoshi Sekiguchi; Tetsuya Toyoda; Kunitada Shimotohno; Tomoyoshi Soga; Masahiro Nishijima; Ryo Taguchi; Michinori Kohara
Journal:  PLoS Pathog       Date:  2012-08-16       Impact factor: 6.823

10.  Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma.

Authors:  Qiang-Bo Zhang; Hui-Chuan Sun; Ke-Zhi Zhang; Qing-An Jia; Yang Bu; Miao Wang; Zong-Tao Chai; Quan-Bao Zhang; Wen-Quan Wang; Ling-Qun Kong; Xiao-dong Zhu; Lu Lu; Wei-Zhong Wu; Lu Wang; Zhao-You Tang
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.